Oncology approvals are on an upward trend
Interviewee/Contributor
Bruno Pagliara
Organisation
MedNous
Research Directory
Finding a link between the microbiome and disease
Interviewee/ContributorSteff TaelmanOrganisationBioLizard NVEnterome starts development of new cancer drugs
Interviewee/ContributorJan FagerbergOrganisationEnterome SAMimicking anti-viral innate immunity against cancer
Interviewee/ContributorAlex Karlsson-Parra and Sijme ZeilemakerOrganisationImmunicum ABChristmas comes early for Europe's biotech stocks
Interviewee/ContributorWilliam EllingtonOrganisationMedNousIntegrated product development for ATMPs
Interviewee/ContributorClaes Buxfeldt and Paula SalmikangasOrganisationNDA Advisory Services LtdThe role of oncolytic viruses in immuno-oncology
Interviewee/ContributorBernard Huber and Paul HighamOrganisationOryx GmbH & Co KG and Valo Therapeutics LtdJ&J plans large Covid-19 vaccine trial
Interviewee/ContributorPeter CharlishOrganisationMedNousInvestors support new antifungal agent
Interviewee/ContributorRalf Schmid and Emma HarveyOrganisationF2G LtdCovid-19: still more questions than answers
Interviewee/ContributorPeter CharlishOrganisationMedNous